Astrazeneca (AZN) said Thursday it will invest CA$820 million ($570 million) in Canada and create over 700 high-skilled jobs across its operations in the country.
The investment includes moving to a larger facility to Greater Toronto Area in Ontario, the company said.
This initiative will support AstraZeneca's $80 billion global revenue goal by 2030 and its plan to launch 20 new medicines within the same timeframe, it added.
The company said it expects seven phase 3 clinical trial data readouts this year.
Price: 68.49, Change: +0.28, Percent Change: +0.42
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。